Financial Performance - AMETEK's Q1 2025 sales were $1.73 billion, consistent with Q1 2024 sales[2] - Operating income increased by 2% to $454.8 million, with operating margins up 60 basis points to 26.3% compared to the prior year[2][3] - Adjusted earnings per diluted share were $1.75, reflecting a 7% increase from Q1 2024[3] - The company reported a net income of $351.8 million for Q1 2025, compared to $310.9 million in Q1 2024[14] Segment Performance - Electronic Instruments Group (EIG) sales were $1.14 billion, down 1% from the previous year, while operating income margins improved to 31.0%[5] - Electromechanical Group (EMG) achieved record sales of $588.3 million, up 2% from Q1 2024, with operating income margins rising to 21.9%[7] Future Outlook - AMETEK expects overall sales for 2025 to increase by low single digits compared to 2024, with adjusted earnings per diluted share projected between $7.02 and $7.18, a 3% to 5% increase[8] Cash Flow and Assets - Free cash flow conversion was 112% in Q1 2025, down from 123% in Q1 2024[21] - Total assets as of March 31, 2025, were $14.88 billion, an increase from $14.63 billion at the end of 2024[19] Growth Strategy - AMETEK's growth model focuses on operational excellence, technology innovation, global market expansion, and strategic acquisitions[10]

Financial Data and Key Metrics Changes - Sales for Q1 2025 were $1,730 million, essentially flat compared to Q1 2024, with organic sales down 1% and acquisitions contributing 1% [6][8] - Operating income increased by 2% to $455 million, with operating margins at 26.3%, up 60 basis points year-over-year [7][8] - EBITDA rose by 3% to $559 million, with EBITDA margins at 32.2% [7][8] - Free cash flow was $394 million, representing a conversion rate of 112% of net income, up 3% from the previous year [8][26] - Diluted earnings per share increased by 7% to $1.75, exceeding the guidance range [8][22] Business Line Data and Key Metrics Changes - **Electronic Instruments Group (EIG)**: Sales were $1,140 million, down 1% year-over-year, with operating income slightly up to $354.1 million and operating margins at 31%, up 50 basis points [9] - **Electromechanical Group (EMG)**: Achieved record sales of $588.3 million, up 2% year-over-year, with operating income increasing by 7% to $128.7 million and operating margins at 21.9%, up 120 basis points [10] Market Data and Key Metrics Changes - Orders overall were up 8% in the quarter, with organic orders increasing by 3% [6][40] - The U.S. market showed positive growth, while international markets experienced modest declines, particularly in China, which was down about 10% [46][48] Company Strategy and Development Direction - The company plans to invest an additional $85 million in 2025 to support global and market expansion strategies, focusing on research, development, and engineering [11][28] - Strategic acquisitions remain the top priority for capital deployment, with a robust pipeline of candidates [15][72] - The company is committed to mitigating tariff impacts through various strategies, including localization of production and pricing initiatives [21][55] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the uncertain economic environment, citing a strong start to the year and improving order patterns [16][22] - The company anticipates full-year sales to increase by low single digits compared to 2024, with diluted earnings per share expected to rise by 3% to 5% [21][22] Other Important Information - The effective tax rate for Q1 was 19%, consistent with the previous year, and capital expenditures for the year are expected to be approximately $155 million [24][25] - The company announced an 11% increase in its quarterly cash dividend to $0.31 per share, marking the sixth consecutive year of significant annual increases [28] Q&A Session Summary Question: Details on Paragon and Medical-related businesses - Management noted that Paragon has seen a notable inflection in orders, with overall orders in the medical segment up 25% in the quarter, indicating a recovery from previous destocking [36][38] Question: Order cadence and demand destruction - Overall orders were up 8%, with organic orders up 3%, indicating continued improvement without significant demand destruction [40][41] Question: Geographic performance and market conditions - Positive growth was observed in the U.S., while modest declines were noted in Europe and Asia, particularly a 10% decline in China [46][48] Question: Tariff impacts and mitigation strategies - The company estimates a $100 million annual tariff impact, with plans to offset this through various mitigation actions [52][55] Question: Margin trajectory for EMG and Paragon - Management expects upside in margins for Paragon in the second half of the year due to ongoing improvement plans and increased volume [67][68] Question: Capital allocation and M&A activity - The company remains active in its M&A pipeline, with a focus on strategic acquisitions despite market uncertainties [71][72]

Financial Data and Key Metrics Changes - Sales for the first quarter of 2025 were $1,730 million, essentially flat compared to the first quarter of 2024, with organic sales down 1% [7] - Operating income increased by 2% to $455 million, with operating margins at 26.3%, up 60 basis points from the prior year [9] - Diluted earnings per share rose by 7% to $1.75, exceeding the guidance range of $1.67 to $1.69 [10] - Free cash flow was $394 million, representing a conversion rate of 112% of net income [10][28] Business Line Data and Key Metrics Changes - **Electronic Instruments Group (EIG)**: Sales were $1,140 million, down 1% year-over-year, with operating income slightly up to $354.1 million and operating margins at 31% [11] - **Electromechanical Group (EMG)**: Achieved record sales of $588.3 million, up 2% year-over-year, with operating income increasing by 7% to $128.7 million and operating margins at 21.9% [12] Market Data and Key Metrics Changes - Overall orders increased by 8%, with organic orders up 3% compared to the previous year [7][40] - The U.S. market showed positive growth, while international markets experienced modest declines, particularly in China, which was down about 10% [48] Company Strategy and Development Direction - The company plans to invest an additional $85 million in 2025 to support global and market expansion strategies, focusing on research, development, and engineering [13] - Strategic acquisitions remain the top priority for capital deployment, with a robust pipeline of attractive candidates [17][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the uncertain economic environment, citing a distributed operating structure that allows for quick responses to market dynamics [19] - The company expects full-year sales to increase by low single digits compared to 2024, with diluted earnings per share projected to be in the range of $7.20 to $7.18, reflecting a 3% to 5% increase [22] Other Important Information - The company has a share repurchase authorization of $1.25 billion and announced an 11% increase in its quarterly cash dividend to $0.31 per share [29] - The effective tax rate for the quarter was 19%, consistent with the previous year, and capital expenditures for the year are expected to be approximately $155 million [26][27] Q&A Session Summary Question: Details on Paragon and medical-related businesses - Management noted that Paragon has seen a notable inflection in orders, with overall orders in the medical-related businesses up 25% in the quarter [36][38] Question: Order cadence and demand destruction - Overall orders were up 8% in the quarter, with a strong order cadence observed, particularly in March [40][41] Question: Geographic performance and market conditions - Positive growth was noted in the U.S., while modest declines were observed in Europe and Asia, with China down about 10% [48] Question: Tariff impacts and mitigation strategies - The estimated annual tariff impact is about $100 million, with plans to offset this through various mitigation actions [56][60] Question: Margin trajectory for EMG and Paragon - Management expects upside in margins for Paragon in the second half of the year due to ongoing improvement plans [71][72] Question: Capital allocation and M&A activity - The company remains active in its M&A pipeline, with some delays due to market uncertainties, but continues to pursue opportunities [75][78]

Core Insights - AMETEK, Inc. reported first quarter 2025 sales of $1.73 billion, consistent with the same period in 2024, while operating income increased by 2% to $454.8 million, resulting in an operating margin of 26.3% [1][2][3] Financial Performance - First quarter earnings per diluted share were $1.52 on a GAAP basis, with adjusted earnings rising 7% to $1.75 per diluted share compared to Q1 2024 [2] - Free cash flow conversion was strong at 112% for the quarter, indicating effective cash management [1][16] Segment Performance - Electronic Instruments Group (EIG) sales were $1.14 billion, down 1% year-over-year, but operating income increased slightly to $354.1 million, with margins at 31.0% [4][12] - Electromechanical Group (EMG) achieved record sales of $588.3 million, up 2% from the previous year, with operating income rising 7% to $128.7 million and margins expanding to 21.9% [5][12] Strategic Outlook - The company anticipates low single-digit sales growth for the year compared to 2024, with adjusted earnings per diluted share projected between $7.02 and $7.18, reflecting a 3% to 5% increase [6][8] - AMETEK's growth model emphasizes operational excellence, technology innovation, global expansion, and strategic acquisitions, which are seen as key differentiators in uncertain macroeconomic conditions [3][8]

Core Viewpoint - Analysts project that Ametek (AME) will report quarterly earnings of $1.69 per share, reflecting a year-over-year increase of 3.1% and revenues of $1.74 billion, which is a 0.3% increase from the same quarter last year [1] Group 1: Earnings Projections - There has been a 0.1% upward revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Group 2: Key Metrics Estimates - Analysts estimate 'Net Sales- Electronic Instruments' to be $1.16 billion, representing a 0.2% increase year over year [5] - 'Net Sales- Electro mechanical' is projected to reach $581.78 million, indicating a 0.4% year-over-year change [5] - 'Operating Income- Electronic Instruments' is forecasted at $347.56 million, down from $352.94 million reported in the same quarter last year [6] - 'Operating Income- Electromechanical' is expected to be $122.95 million, up from $90.69 million in the previous year [6] Group 3: Stock Performance - Over the past month, Ametek shares have declined by 3.4%, compared to a 0.8% decrease in the Zacks S&P 500 composite [6] - Ametek holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the near term [6]

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Ametek, with a focus on how actual results compare to estimates, which could significantly impact stock price [1][2]. Company Summary - Ametek is expected to report quarterly earnings of $1.69 per share, reflecting a year-over-year increase of +3.1% [3]. - Revenues are projected to be $1.74 billion, indicating a slight increase of 0.3% from the previous year [3]. - The consensus EPS estimate has been revised 0.14% higher in the last 30 days, suggesting a positive reassessment by analysts [4]. Earnings Prediction Insights - The Zacks Earnings ESP model indicates that Ametek has a positive Earnings ESP of +0.51%, suggesting analysts are optimistic about the company's earnings prospects [10][11]. - However, Ametek currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [11]. - Historically, Ametek has beaten consensus EPS estimates in the last four quarters, with a surprise of +1.63% in the most recent quarter [12][13]. Industry Context - Cognex Corporation, another player in the electronics-testing equipment industry, is expected to report earnings of $0.13 per share, representing a year-over-year increase of +18.2% [17]. - Cognex's revenues are anticipated to decline by 3.1% to $204.35 million [17]. - The consensus EPS estimate for Cognex has been revised down by 7.1% in the last 30 days, resulting in a negative Earnings ESP of -6.72% [18].

Financial Performance - In 2024, the Company achieved record sales of $6,941.2 million, an increase of 5.2% from 2023[29]. - Diluted earnings per share for 2024 were a record $5.93, an increase of $0.26 or 4.5% compared to $5.67 per diluted share in 2023[29]. - The company's operating income for 2024 was $1,779.56 million, up from $1,707.46 million in 2023, reflecting a growth of 4.2%[224]. - Net income for 2024 reached $1,376.12 million, compared to $1,313.19 million in 2023, marking an increase of 4.8%[224]. - Basic earnings per share increased to $5.95 in 2024 from $5.70 in 2023, a rise of 4.4%[224]. - Consolidated net sales for 2024 reached $6,941.2 million, an increase from $6,596.9 million in 2023, representing a growth of approximately 5.2%[290][292]. - Net sales in the United States for 2024 were $3,649.4 million, compared to $3,468.8 million in 2023, reflecting a growth of approximately 5.2%[290][292]. - International net sales totaled $3,291.7 million in 2024, up from $3,128.2 million in 2023, marking an increase of about 5.2%[290][292]. - Cash provided by operating activities totaled $1,828,848 in 2024, compared to $1,735,296 in 2023, indicating an increase of 5.4%[234]. Acquisitions - In October 2024, the Company acquired Virtek Vision International for $117.5 million, enhancing its capabilities in advanced laser-based projection and inspection systems[30]. - The company acquired Virtek Vision International in October 2024, which constituted 0.9% of total assets and 0.2% of net sales for the year ended December 31, 2024[198]. - The company completed the acquisition of Paragon Medical in December 2023 for $1.9 billion, with $852.3 million allocated to intangible assets as of December 31, 2024[216][218]. - The total cash spent on acquisitions in 2023 amounted to $2,237.9 million, including Paragon Medical, Amplifier Research Corp., United Electronic Industries, and Bison Gear & Engineering Corp.[320]. - The Company finalized its acquisition of Paragon Medical, resulting in an increase of $62.2 million in goodwill and no material impact on the consolidated statement of income[319]. - The Company acquired Kern Microtechnik in January 2025, which has annual sales of approximately €50 million, further expanding its market presence[324]. Sales Composition - Process and analytical instrumentation sales represented 69% of EIG's 2024 net sales, serving industries such as power generation and pharmaceutical manufacturing[37]. - Aerospace and power instrumentation sales accounted for 31% of EIG's 2024 net sales, focusing on power monitoring and metering instruments[39]. - EMG's automation and engineered solutions markets represented 73% of its 2024 net sales, highlighting its focus on precision motion control solutions[51]. - Approximately 6% of EIG's 2024 net sales were made to its five largest customers, with no single customer comprising more than 2% of net sales[46]. - The Company’s major product segment, Process and Analytical Instrumentation, generated $3,232.9 million in sales for 2024, compared to $3,267.7 million in 2023, showing a slight decline of about 1.1%[294][296]. - Products transferred at a point in time accounted for $5,792.1 million of consolidated net sales in 2024, compared to $5,603.7 million in 2023, indicating an increase of approximately 3.4%[297]. International Presence - In 2024, 51% of EIG's net sales were to customers outside the United States, indicating a strong international presence[36]. - In 2024, 41% of EMG's net sales were to customers outside the United States, reflecting its global market reach[50]. Employee and Community Engagement - As of December 31, 2024, AMETEK has approximately 21,500 employees, with compensation programs designed to attract and retain a world-class workforce[77]. - The company actively engages in community support through the AMETEK Foundation, focusing on health, welfare, civic, and educational programs[73]. - The company has established a leadership development program for employees on track to become P&L leaders, involving both internal and external training[76]. - AMETEK's executive management team regularly reviews key talent to assess adequacy for future growth needs[75]. Financial Controls and Reporting - AMETEK's internal control over financial reporting was assessed as effective as of December 31, 2024, based on the COSO criteria[202]. - The company maintains a system of internal controls designed to provide reasonable assurance regarding the reliability of financial reporting[193]. - AMETEK's financial statements are prepared in conformity with U.S. generally accepted accounting principles, ensuring the integrity of financial information[191]. Sustainability and Innovation - AMETEK's commitment to sustainability includes a growing portfolio of clean technology solutions aimed at reducing carbon emissions and promoting renewable energy[72]. - The Company recorded research and development costs of $236.6 million in 2024, $220.8 million in 2023, and $198.8 million in 2022, indicating a year-over-year increase of approximately 7.9% from 2023 to 2024[273]. Asset and Liability Management - As of December 31, 2024, the total assets of AMETEK, Inc. were $14,631.17 million, a decrease from $15,023.53 million in 2023[229]. - Total liabilities decreased to $4,975.87 million in 2024 from $6,293.34 million in 2023, indicating a reduction of 20.9%[229]. - The fair value of long-term debt (including current portion) decreased to $1,778.7 million in 2024 from $2,087.6 million in 2023, a reduction of approximately 14.8%[309]. - The goodwill balance increased to $6,555.9 million as of December 31, 2024, reflecting recent acquisitions and adjustments[325]. - The balance of retained earnings at the end of 2024 was $11,057,684, compared to $9,940,343 at the end of 2023, marking an increase of 11.3%[232].

AMETEK OVERVIEW Clear vision and sound strategy built on core values 3 FIRST QUARTER 2025 INVESTOR PRESENTATION CAUTIONARY STATEMENTS Statements in this presentation that are not historical in nature are considered "forward-looking statements" and are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. Those factors are contained in AMETEK's Securities and Exchange Commission filings. AMETEK disclaims any intention or obl ...

Financial Performance - AMETEK's Q4 2024 sales reached a record $1.76 billion, a 2% increase from Q4 2023[2] - Operating income for Q4 2024 increased by 5% to a record $469.0 million, with operating margins at 26.6%, up 90 basis points year-over-year[2] - Full year 2024 sales totaled $6.94 billion, reflecting a 5% increase compared to 2023[4] - Full year adjusted operating income was $1.81 billion, up 6% from the previous year, with adjusted operating income margins at 26.1%[5] - Operating cash flow for the full year 2024 was $1.83 billion, a 5% increase from 2023[4] Earnings - Adjusted earnings per diluted share for Q4 2024 were a record $1.87, an 11% increase from Q4 2023[3] - Diluted earnings per share (GAAP) for Q4 2024 was $1.67, up from $1.48 in Q4 2023, representing a 12.8% increase[27] - Adjusted diluted earnings per share (Non-GAAP) for Q4 2024 was $1.87, compared to $1.68 in Q4 2023, reflecting an 11.3% growth[27] - For the year ended December 31, 2024, diluted earnings per share (GAAP) increased to $5.93 from $5.67 in 2023, a rise of 4.6%[27] - The forecasted diluted earnings per share (GAAP) for Q1 2025 is projected to be between $1.46 and $1.48[27] - The forecasted adjusted diluted earnings per share (Non-GAAP) for Q1 2025 is expected to range from $1.67 to $1.69[27] Cash Flow - Free cash flow for Q4 2024 was a record $498.3 million, with a free cash flow to net income conversion rate of 129%[2] Segment Performance - Electronic Instruments Group (EIG) sales in Q4 2024 were $1.21 billion, down 2% from Q4 2023, while operating income increased 8% to $386.6 million[8] - Electromechanical Group (EMG) sales in Q4 2024 rose by 11% to $546.7 million, driven by the acquisition of Paragon Medical and growth in Aerospace and Defense sectors[9] Non-GAAP Financial Information - The company emphasizes the use of non-GAAP financial information to provide investors with greater insight into operational performance[29] - Non-GAAP measures are intended to enhance understanding of long-term profitability trends and facilitate comparisons with peers[30] - The reconciliation of non-GAAP measures to GAAP measures is included in the financial tables for transparency[29] Amortization and Tax - The company reported pretax amortization of acquisition-related intangible assets of $0.27 for Q4 2023, slightly increasing to $0.28 in Q1 2025 forecast[27] - The income tax benefit on amortization of acquisition-related intangible assets was $(0.07) for Q1 2025 forecast, consistent with the previous quarter[27]

Financial Data and Key Metrics Changes - Third quarter sales were $1.71 billion, up 5% from the same period in 2023, with organic sales down 2% and acquisitions contributing 7.5 points [9][11] - Operating income increased to $446 million, a 2% increase over the third quarter of 2023, with operating margins at 26.1% [10] - EBITDA was $553 million, up 4% year-over-year, with EBITDA margins at 31.2% [11] - Earnings per diluted share were $1.66, up 1% from the third quarter of 2023, exceeding guidance [11] - Free cash flow was $461 million, up 4% year-over-year, with a free cash flow conversion rate of 135% [32] Business Line Data and Key Metrics Changes - **Electronic Instruments Group (EIG)**: Sales were $1.13 billion, organic sales down 2%, with operating income at $339 million and operating margins at 29.9% [12][13] - **Electromechanical Group (EMG)**: Sales were $574 million, up 18% year-over-year, with organic sales down 3% and operating income at $132 million, operating margins at 22.9% [14][15] Market Data and Key Metrics Changes - Strong growth in Aerospace & Defense, with mid-single-digit growth in both overall and organic sales [44] - Power and industrial businesses saw mid-single-digit growth driven by recent acquisitions, while organic sales were down low single digits [45] - Automation & Engineered Solutions market segment sales increased in the low 20% range, but organic sales declined high single digits due to inventory normalization [46] - Asia business grew, with China up 10%, while the US experienced some declines [47] Company Strategy and Development Direction - The company is focused on strategic acquisitions as a core component of its growth model, recently acquiring Virtek Vision [17][19] - Plans to invest an additional $90 million in growth initiatives, including new product development [21] - The Vitality Index, measuring sales from products introduced over the past three years, was 28% [22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating macroeconomic challenges and maintaining long-term growth [25] - The company raised its earnings guidance for the full year, expecting sales to be up 5% to 7% and diluted earnings per share in the range of $6.77 to $6.82 [24] - Management noted that destocking issues are expected to continue but are not indicative of overall demand decline [39][49] Other Important Information - The company ended the quarter with a strong backlog of $3.44 billion [9] - Total debt was $2.34 billion, down $360 million in the quarter, with cash and cash equivalents of $396 million [34] Q&A Session Summary Question: Update on medical and life sciences markets - Management noted that destocking is occurring as OEM customers work down excess inventory, but order trends are stabilizing [38] Question: Comments on end markets and China - Aerospace & Defense showed strong performance, while the process business saw low single-digit declines [43][44] Question: Impact of project delays - Project delays were noted in the EIG test and measurement businesses, but the order funnel remains strong [40] Question: Update on Paragon and EMG orders - Paragon is well-positioned for future growth, and all divisions within EMG saw substantial order increases [55][54] Question: Acquisition pipeline and market conditions - The acquisition pipeline remains robust, with management feeling optimistic about upcoming opportunities [65] Question: Price and cost spread outlook - Price increases were noted at three points across the portfolio, with a positive spread to the P&L [97]